Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 36, 2026)
Company announcement No. 46 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 36, 2026) Copenhagen, Denmark, September 7, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Fosun Pharma to repurchase H shares with proposed amount up to $1 billion
Fosun Pharma (2196) announced plans to repurchase H shares of the company, with the proposed total amount of funds for repurchasing H Shares of up to HK$1 billion. SCROLL TO CONTINUE WITH CONTENT The use of such repurchased H shares will be decided…
How Shravan Parsi went from pharma labs to 4,400 apartment units in Texas real estate
Around 70% of ten-year-olds in low- and middle-income countries cannot read and understand a simple written text, the World Bank estimated after the pandemic, up from 57% in 2019, a deficit the bank prices at $21 trillion in lost lifetime earnings…
Ascendis Pharma A/S $ASND Shares Bought by Frazier Life Sciences Management L.P.
Frazier Life Sciences Management L.P. raised its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 68.9% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 225,155 shares of the…
Royalty Pharma PLC $RPRX Position Increased by TD Waterhouse Canada Inc.
TD Waterhouse Canada Inc. grew its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 121.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm…
Legal & General Group Plc Invests $1.32 Million in Urogen Pharma $URGN
Legal & General Group Plc purchased a new position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased…
Frazier Life Sciences Management L.P. Has $613.03 Million Stake in NewAmsterdam Pharma Company N.V. $NAMS
Frazier Life Sciences Management L.P. lifted its stake in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 6.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The…
Frazier Life Sciences Management L.P. Sells 1,900,000 Shares of BridgeBio Pharma, Inc. $BBIO
Frazier Life Sciences Management L.P. decreased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 55.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The…
Stocks to watch, Sept 7: 3 Tata group cos, 4 Railway stocks, 2 shipping sector, 3 Pharma majors, Adani Enterprises, NMDC, SJVN, Nava, Stanley Lifestyle will remain in focus
HyperVault, a subsidiary of Tata Consultancy Services (TCS), on Saturday announced that it has secured 264 acres of land in Hyderabad to develop a large-scale artificial intelligence data centre campus with a total investment outlay of up to Rs…
Swiss labour market remains strong
This was stated by Jérôme Cosandey, head of the labour division at the State Secretariat for Economic Affairs (SECO), while commenting via teleconference on the unemployment figures (3% in August). The only significant increase was…
US India Space Co-Creation: Powering Future Human Discovery
US Ambassador Sergio Gor announced a new phase in US-India space relations, shifting from mere cooperation to 'co-creation,' promising joint ventures in design, funding, and the future of human discovery, including India's role in the Artemis…
Seoul shares sharply up late Monday morning on strong chip gains
Korean stocks traded sharply higher late Monday morning as investors scooped up semiconductor shares on optimism on further artificial intelligence (AI)-related demand. Opening 3.34 percent higher, the benchmark Korea Composite Stock Price Index…
PharmaMar: Expensive Multiples For Zepzelca's Growth (OTCMKTS:PHMMF)
Pharma Mar is increasingly reliant on Zepzelca, even though Yondelis gives them a smaller recurring-revenue base today. Their first-line maintenance uptake is helping US royalties, while Germany and Austria give PHMMF another interesting European…
Novartis Heart-Drug Flop Deepens Pipeline Setbacks, Hits Rivals
Novartis AG suffered a second trial disappointment within a week after the Swiss pharma group's potential blockbuster heart drug failed in a final-stage study. The drug, pelacarsen, did lower levels of lipoprotein(a), a largely genetic risk factor…
India should target 10 million international patients a year: Goyal
Commerce and Industry Minister Piyush Goyal on Monday called on India's pharmaceutical and healthcare industry to build globally competitive medical devices and scale up medical value tourism, setting a target of 10 million international patients a…
Receive a Daily briefing on Pharma Industry News
Get Started